{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:03:36Z","timestamp":1794006216370,"version":"4.8.0"},"reference-count":123,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["TL1TR002371"],"award-info":[{"award-number":["TL1TR002371"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI145835-03"],"award-info":[{"award-number":["R01AI145835-03"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Yellow fever virus, family Orthoflaviviridae, is the causative agent of yellow fever \u2013 a lethal mosquito-borne disease endemic to South America and Africa. Recent advances in understanding the mechanism of orthoflavivirus pathogenesis, particularly for dengue (DENV), demonstrate a role for the secreted viral non-structural protein 1 (NS1) in both animal and human models. The NS1 protein\u2019s most well described pathogenic mechanism is its ability to induce vascular endothelial permeability in a tissue organ specific manner, contributing to orthoflavivirus disease severity. Surprisingly, there is minimal research published on the role of NS1 in YFV pathogenesis, despite the clear and present danger of YFV outbreaks in endemic countries. Understanding the role of NS1 in YFV pathogenesis is critical for the development of therapeutic interventions. Notably, while vaccination efforts for orthoflaviviruses have been historically difficult, the live attenuated vaccine (YFV-17D) against YFV has been hailed as not only the most successful orthoflavivirus vaccine but is among the most successful live virus vaccines ever created. Despite YFV-17D\u2019s widespread use since its introduction in the 1930\u2019s, the best described mechanism of protection is the vaccine\u2019s potent neutralizing antibodies. Our knowledge of NS1 pathogenic mechanisms has expanded since the development of YFV-17D, but how vaccine mediated immunity may interact with NS1 during natural YFV infection is not well described. In this review we describe the current knowledge of YFV NS1 mediated pathogenesis and adaptive immunity directed against YFV NS1 in a variety of animal and human models.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1186\/s12985-025-02955-9","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:36:06Z","timestamp":1761042966000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Endothelial leak and knowledge gaps: yellow fever virus non-structural protein 1 and the antibodies that bind it"],"prefix":"10.1186","volume":"22","author":[{"given":"Samantha R.","family":"Osman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William B.","family":"Messer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"key":"2955_CR1","unstructured":"Created. in BioRender. Messer, W. (2025)."},{"key":"2955_CR2","unstructured":"(WHO) WHO. Yellow Fever 2023 [Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/yellow-fever]"},{"issue":"6","key":"2955_CR3","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/s41564-020-0714-0","volume":"5","author":"TC Pierson","year":"2020","unstructured":"Pierson TC, Diamond MS. The continued threat of emerging flaviviruses. Nat Microbiol. 2020;5(6):796\u2013812.","journal-title":"Nat Microbiol"},{"issue":"1","key":"2955_CR4","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1080\/22221751.2019.1568180","volume":"8","author":"FVS Abreu","year":"2019","unstructured":"Abreu FVS, Ribeiro IP, Ferreira-de-Brito A, Santos A, Miranda RM, Bonelly IS, et al. Haemagogus Leucocelaenus and haemagogus janthinomys are the primary vectors in the major yellow fever outbreak in Brazil, 2016\u20132018. Emerg Microbes Infect. 2019;8(1):218\u201331.","journal-title":"Emerg Microbes Infect"},{"issue":"1","key":"2955_CR5","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/s41467-024-45116-2","volume":"15","author":"G Gabiane","year":"2024","unstructured":"Gabiane G, Bohers C, Mousson L, Obadia T, Dinglasan RR, Vazeille M, et al. Evaluating vector competence for yellow fever in the Caribbean. Nat Commun. 2024;15(1):1236.","journal-title":"Nat Commun"},{"key":"2955_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmni.2025.101580","volume":"65","author":"RN Angerami","year":"2025","unstructured":"Angerami RN, Socorro Souza Chaves TD, Rodriguez-Morales AJ. Yellow fever outbreaks in South America: current epidemiology, legacies of the recent past and perspectives for the near future. New Microbes New Infect. 2025;65:101580.","journal-title":"New Microbes New Infect"},{"issue":"7","key":"2955_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005738","volume":"12","author":"H Puerta-Guardo","year":"2016","unstructured":"Puerta-Guardo H, Glasner DR, Harris E. Dengue virus NS1 disrupts the endothelial glycocalyx, leading to hyperpermeability. PLoS Pathog. 2016;12(7):e1005738.","journal-title":"PLoS Pathog"},{"issue":"7","key":"2955_CR8","doi-asserted-by":"publisher","first-page":"6104","DOI":"10.1128\/JVI.73.7.6104-6110.1999","volume":"73","author":"M Flamand","year":"1999","unstructured":"Flamand M, Megret F, Mathieu M, Lepault J, Rey FA, Deubel V. Dengue virus type 1 nonstructural glycoprotein NS1 is secreted from mammalian cells as a soluble hexamer in a glycosylation-dependent fashion. J Virol. 1999;73(7):6104\u201310.","journal-title":"J Virol"},{"issue":"6525","key":"2955_CR9","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1126\/science.abb9425","volume":"371","author":"N Modhiran","year":"2021","unstructured":"Modhiran N, Song H, Liu L, Bletchly C, Brillault L, Amarilla AA, et al. A broadly protective antibody that targets the flavivirus NS1 protein. Science. 2021;371(6525):190\u20134.","journal-title":"Science"},{"issue":"1","key":"2955_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-15039-8","volume":"7","author":"AC Brault","year":"2017","unstructured":"Brault AC, Domi A, McDonald EM, Talmi-Frank D, McCurley N, Basu R, et al. A Zika vaccine targeting NS1 protein protects immunocompetent adult mice in a lethal challenge model. Sci Rep. 2017;7(1):14769.","journal-title":"Sci Rep"},{"issue":"1","key":"2955_CR11","doi-asserted-by":"publisher","first-page":"4560","DOI":"10.1038\/s41467-018-07008-0","volume":"9","author":"MJ Bailey","year":"2018","unstructured":"Bailey MJ, Duehr J, Dulin H, Broecker F, Brown JA, Arumemi FO, et al. Human antibodies targeting Zika virus NS1 provide protection against disease in a mouse model. Nat Commun. 2018;9(1):4560.","journal-title":"Nat Commun"},{"issue":"12","key":"2955_CR12","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aax2388","volume":"5","author":"B Grubor-Bauk","year":"2019","unstructured":"Grubor-Bauk B, Wijesundara DK, Masavuli M, Abbink P, Peterson RL, Prow NA, et al. NS1 DNA vaccination protects against Zika infection through T cell-mediated immunity in immunocompetent mice. Sci Adv. 2019;5(12):eaax2388.","journal-title":"Sci Adv"},{"key":"2955_CR13","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1093\/molbev\/msz312","volume":"37","author":"G Stecher","year":"2020","unstructured":"Stecher G, Tamura K, Kumar S. Molecular evolutionary genetics analysis (MEGA) for macOS. Mol Biol Evol. 2020;37:1237\u20139.","journal-title":"Mol Biol Evol"},{"issue":"5","key":"2955_CR14","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/rmv.1752","volume":"23","author":"JA Quaresma","year":"2013","unstructured":"Quaresma JA, Pagliari C, Medeiros DB, Duarte MI, Vasconcelos PF. Immunity and immune response, pathology and pathologic changes: progress and challenges in the immunopathology of yellow fever. Rev Med Virol. 2013;23(5):305\u201318.","journal-title":"Rev Med Virol"},{"issue":"7","key":"2955_CR15","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/S1473-3099(19)30125-2","volume":"19","author":"EG Kallas","year":"2019","unstructured":"Kallas EG, D\u2019Elia Zanella L, Moreira CHV, Buccheri R, Diniz GBF, Castineiras ACP, et al. Predictors of mortality in patients with yellow fever: an observational cohort study. Lancet Infect Dis. 2019;19(7):750\u20138.","journal-title":"Lancet Infect Dis"},{"key":"2955_CR16","doi-asserted-by":"publisher","first-page":"109321","DOI":"10.1016\/j.clim.2023.109321","volume":"251","author":"JRB Fradico","year":"2023","unstructured":"Fradico JRB, Campi-Azevedo AC, Speziali E, do Valle Antonelli LR, Peruhype-Magalh\u00e3es V, de Rezende IM, et al. Serum soluble mediators as prognostic biomarkers for morbidity, disease outcome, and late-relapsing hepatitis in yellow fever patients. Clin Immunol. 2023;251:109321.","journal-title":"Clin Immunol"},{"issue":"10","key":"2955_CR17","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1086\/425016","volume":"190","author":"J ter Meulen","year":"2004","unstructured":"ter Meulen J, Sakho M, Koulemou K, Magassouba N, Bah A, Preiser W, et al. Activation of the cytokine network and unfavorable outcome in patients with yellow fever. J Infect Dis. 2004;190(10):1821\u20137.","journal-title":"J Infect Dis"},{"key":"2955_CR18","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jcv.2014.08.030","volume":"64","author":"TP Monath","year":"2015","unstructured":"Monath TP, Vasconcelos PF. Yellow fever. J Clin Virol. 2015;64:160\u201373.","journal-title":"J Clin Virol"},{"issue":"1","key":"2955_CR19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.virol.2005.09.058","volume":"345","author":"JA Quaresma","year":"2006","unstructured":"Quaresma JA, Barros VL, Pagliari C, Fernandes ER, Guedes F, Takakura CF, et al. Revisiting the liver in human yellow fever: virus-induced apoptosis in hepatocytes associated with TGF-beta, TNF-alpha and NK cells activity. Virology. 2006;345(1):22\u201330.","journal-title":"Virology"},{"key":"2955_CR20","doi-asserted-by":"crossref","unstructured":"da Costa Lopes J, Falcao LFM, Martins Filho AJ, Carvalho MLG, Mendes CCH, Olimpio FA, et al. Factors Involved in the Apoptotic Cell Death Mechanism in Yellow Fever Hepatitis. Viruses. 2022;14(6).","DOI":"10.3390\/v14061204"},{"key":"2955_CR21","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S0065-3527(03)60009-6","volume":"60","author":"TP Monath","year":"2003","unstructured":"Monath TP, Barrett AD. Pathogenesis and pathophysiology of yellow fever. Adv Virus Res. 2003;60:343\u201395.","journal-title":"Adv Virus Res"},{"issue":"8","key":"2955_CR22","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1038\/s41564-025-02047-y","volume":"10","author":"J Zhang","year":"2025","unstructured":"Zhang J, Chavez EC, Winkler M, Liu J, Carver S, Lin AE, et al. Amino acid changes in two viral proteins drive attenuation of the yellow fever 17D vaccine. Nat Microbiol. 2025;10(8):1902\u201317.","journal-title":"Nat Microbiol"},{"issue":"1","key":"2955_CR23","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.antiviral.2007.10.009","volume":"78","author":"TP Monath","year":"2008","unstructured":"Monath TP. Treatment of yellow fever. Antivir Res. 2008;78(1):116\u201324.","journal-title":"Antivir Res"},{"issue":"4","key":"2955_CR24","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1586\/14760584.4.4.553","volume":"4","author":"TP Monath","year":"2005","unstructured":"Monath TP. Yellow fever vaccine. Expert Rev Vaccines. 2005;4(4):553\u201374.","journal-title":"Expert Rev Vaccines"},{"issue":"12","key":"2955_CR25","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1093\/infdis\/jiz374","volume":"221","author":"BW Kareko","year":"2020","unstructured":"Kareko BW, Booty BL, Nix CD, Lyski ZL, Slifka MK, Amanna IJ, et al. Persistence of neutralizing antibody responses among yellow fever virus 17D vaccinees living in a nonendemic setting. J Infect Dis. 2020;221(12):2018\u201325.","journal-title":"J Infect Dis"},{"issue":"4","key":"2955_CR26","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1128\/am.25.4.539-544.1973","volume":"25","author":"RA Mason","year":"1973","unstructured":"Mason RA, Tauraso NM, Spertzel RO, Ginn RK. Yellow fever vaccine: direct challenge of monkeys given graded doses of 17D vaccine. Appl Microbiol. 1973;25(4):539\u201344.","journal-title":"Appl Microbiol"},{"issue":"689","key":"2955_CR27","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.ade5795","volume":"15","author":"MJ Ricciardi","year":"2023","unstructured":"Ricciardi MJ, Rust LN, Pedreno-Lopez N, Yusova S, Biswas S, Webb GM, et al. Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infection. Sci Transl Med. 2023;15(689):eade5795.","journal-title":"Sci Transl Med"},{"issue":"3","key":"2955_CR28","doi-asserted-by":"publisher","first-page":"e0051222","DOI":"10.1128\/mbio.00512-22","volume":"13","author":"MP Doyle","year":"2022","unstructured":"Doyle MP, Genualdi JR, Bailey AL, Kose N, Gainza C, Rodriguez J, et al. Isolation of a potently neutralizing and protective human monoclonal antibody targeting yellow fever virus. mBio. 2022;13(3):e0051222.","journal-title":"mBio"},{"issue":"6","key":"2955_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003458","volume":"9","author":"O Vratskikh","year":"2013","unstructured":"Vratskikh O, Stiasny K, Zlatkovic J, Tsouchnikas G, Jarmer J, Karrer U, et al. Dissection of antibody specificities induced by yellow fever vaccination. PLoS Pathog. 2013;9(6):e1003458.","journal-title":"PLoS Pathog"},{"issue":"2","key":"2955_CR30","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.celrep.2018.12.065","volume":"26","author":"X Lu","year":"2019","unstructured":"Lu X, Xiao H, Li S, Pang X, Song J, Liu S, et al. Double lock of a human neutralizing and protective monoclonal antibody targeting the yellow fever virus envelope. Cell Rep. 2019;26(2):438\u201346. e5.","journal-title":"Cell Rep"},{"issue":"17","key":"2955_CR31","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1016\/j.vaccine.2023.03.022","volume":"41","author":"R De Santis","year":"2023","unstructured":"De Santis R, Faggioni G, Amoroso A, Ciammaruconi A, Pomponi A, Stella Lia M, et al. Durability of neutralizing antibodies against yellow fever virus after vaccination in healthy adults. Vaccine. 2023;41(17):2761\u20133.","journal-title":"Vaccine"},{"issue":"15","key":"2955_CR32","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1016\/j.vaccine.2005.12.055","volume":"24","author":"MJ Hepburn","year":"2006","unstructured":"Hepburn MJ, Kortepeter MG, Pittman PR, Boudreau EF, Mangiafico JA, Buck PA, et al. Neutralizing antibody response to booster vaccination with the 17d yellow fever vaccine. Vaccine. 2006;24(15):2843\u20139.","journal-title":"Vaccine"},{"issue":"2","key":"2955_CR33","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.chom.2021.12.009","volume":"30","author":"D Haslwanter","year":"2022","unstructured":"Haslwanter D, Lasso G, Wec AZ, Furtado ND, Raphael LMS, Tse AL, et al. Genotype-specific features reduce the susceptibility of South American yellow fever virus strains to vaccine-induced antibodies. Cell Host Microbe. 2022;30(2):248\u2013. \u2013\u200959.e6.","journal-title":"Cell Host Microbe"},{"issue":"5","key":"2955_CR34","doi-asserted-by":"publisher","first-page":"e0370323","DOI":"10.1128\/spectrum.03703-23","volume":"12","author":"AP Goncalves","year":"2024","unstructured":"Goncalves AP, Almeida LT, Rezende I, Fradico JRB, Pereira LS, Ramalho DB, et al. Evaluation of humoral immune response after yellow fever infection: an observational study on patients from the 2017\u20132018 sylvatic outbreak in Brazil. Microbiol Spectr. 2024;12(5):e0370323.","journal-title":"Microbiol Spectr"},{"issue":"6173","key":"2955_CR35","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1126\/science.1247749","volume":"343","author":"DL Akey","year":"2014","unstructured":"Akey DL, Brown WC, Dutta S, Konwerski J, Jose J, Jurkiw TJ, et al. Flavivirus NS1 structures reveal surfaces for associations with membranes and the immune system. Science. 2014;343(6173):881\u20135.","journal-title":"Science"},{"issue":"1","key":"2955_CR36","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1006\/viro.1996.0406","volume":"222","author":"IR Muylaert","year":"1996","unstructured":"Muylaert IR, Chambers TJ, Galler R, Rice CM. Mutagenesis of the N-linked glycosylation sites of the yellow fever virus NS1 protein: effects on virus replication and mouse neurovirulence. Virology. 1996;222(1):159\u201368.","journal-title":"Virology"},{"issue":"2\u20133","key":"2955_CR37","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/0168-1702(91)90025-Q","volume":"18","author":"PR Post","year":"1991","unstructured":"Post PR, Carvalho R, Galler R. Glycosylation and secretion of yellow fever virus nonstructural protein NS1. Virus Res. 1991;18(2\u20133):291\u2013302.","journal-title":"Virus Res"},{"issue":"2","key":"2955_CR38","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.virol.2011.02.022","volume":"413","author":"P Somnuke","year":"2011","unstructured":"Somnuke P, Hauhart RE, Atkinson JP, Diamond MS, Avirutnan P. N-linked glycosylation of dengue virus NS1 protein modulates secretion, cell-surface expression, hexamer stability, and interactions with human complement. Virology. 2011;413(2):253\u201364.","journal-title":"Virology"},{"issue":"1","key":"2955_CR39","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/0042-6822(88)90408-4","volume":"162","author":"G Winkler","year":"1988","unstructured":"Winkler G, Randolph VB, Cleaves GR, Ryan TE, Stollar V. Evidence that the mature form of the flavivirus nonstructural protein NS1 is a dimer. Virology. 1988;162(1):187\u201396.","journal-title":"Virology"},{"issue":"18","key":"2955_CR40","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adm8275","volume":"10","author":"Q Pan","year":"2024","unstructured":"Pan Q, Jiao H, Zhang W, Chen Q, Zhang G, Yu J, et al. The step-by-step assembly mechanism of secreted flavivirus NS1 tetramer and hexamer captured at atomic resolution. Sci Adv. 2024;10(18):eadm8275.","journal-title":"Sci Adv"},{"issue":"19","key":"2955_CR41","doi-asserted-by":"publisher","first-page":"8003","DOI":"10.1073\/pnas.1017338108","volume":"108","author":"I Gutsche","year":"2011","unstructured":"Gutsche I, Coulibaly F, Voss JE, Salmon J, d\u2019Alayer J, Ermonval M, et al. Secreted dengue virus nonstructural protein NS1 is an atypical barrel-shaped high-density lipoprotein. Proc Natl Acad Sci U S A. 2011;108(19):8003\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"0077340","key":"2955_CR42","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1099\/0022-1317-71-3-593","volume":"71","author":"JJ Schlesinger","year":"1990","unstructured":"Schlesinger JJ, Brandriss MW, Putnak JR, Walsh EE. Cell surface expression of yellow fever virus non-structural glycoprotein NS1: consequences of interaction with antibody. J Gen Virol. 1990;71(0077340):593\u20139. (Pt 3)(i9b.","journal-title":"J Gen Virol"},{"key":"2955_CR43","doi-asserted-by":"crossref","unstructured":"Xu X, Vaughan K, Weiskopf D, Grifoni A, Diamond MS, Sette A, et al. Identifying Candidate Targets of Immune Responses in Zika Virus Based on Homology to Epitopes in Other Flavivirus Species. PLoS Curr. 2016;8.","DOI":"10.1371\/currents.outbreaks.9aa2e1fb61b0f632f58a098773008c4b"},{"issue":"1","key":"2955_CR44","doi-asserted-by":"publisher","first-page":"e01956","DOI":"10.1128\/mBio.01956-15","volume":"7","author":"MD Fernandez-Garcia","year":"2016","unstructured":"Fernandez-Garcia MD, Meertens L, Chazal M, Hafirassou ML, Dejarnac O, Zamborlini A, et al. Vaccine and Wild-Type strains of yellow fever virus engage distinct entry mechanisms and differentially stimulate antiviral immune responses. mBio. 2016;7(1):e01956\u201315.","journal-title":"mBio"},{"key":"2955_CR45","doi-asserted-by":"crossref","unstructured":"van den Elsen K, Quek JP, Luo D. Molecular Insights into the Flavivirus Replication Complex. Viruses. 2021;13(6).","DOI":"10.3390\/v13060956"},{"issue":"4","key":"2955_CR46","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.bbrc.2017.01.041","volume":"492","author":"NJ da Fonseca","year":"2017","unstructured":"da Fonseca NJ, Lima Afonso MQ, Pedersolli NG, de Oliveira LC, Andrade DS, Bleicher L. Sequence, structure and function relationships in flaviviruses as assessed by evolutive aspects of its conserved non-structural protein domains. Biochem Biophys Res Commun. 2017;492(4):565\u201371.","journal-title":"Biochem Biophys Res Commun"},{"issue":"36","key":"2955_CR47","doi-asserted-by":"publisher","first-page":"e2305093","DOI":"10.1002\/advs.202305093","volume":"10","author":"Y Ci","year":"2023","unstructured":"Ci Y, Han K, Kong J, Huang S, Yang Y, Qin CF, et al. Flavivirus concentrates host ER in main replication compartments to facilitate replication. Adv Sci (Weinh). 2023;10(36):e2305093.","journal-title":"Adv Sci (Weinh)"},{"key":"2955_CR48","doi-asserted-by":"crossref","unstructured":"Ci Y, Liu Z-Y, Zhang N-N, Niu Y, Yang Y, Xu C, et al. Zika NS1\u2013induced ER remodeling is essential for viral replication. J Cell Biol. 2020;219(2).","DOI":"10.1083\/jcb.201903062"},{"issue":"3","key":"2955_CR49","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/nrmicro.2017.170","volume":"16","author":"CJ Neufeldt","year":"2018","unstructured":"Neufeldt CJ, Cortese M, Acosta EG, Bartenschlager R. Rewiring cellular networks by members of the flaviviridae family. Nat Rev Microbiol. 2018;16(3):125\u201342.","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"2955_CR50","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.chom.2009.03.007","volume":"5","author":"S Welsch","year":"2009","unstructured":"Welsch S, Miller S, Romero-Brey I, Merz A, Bleck CK, Walther P, et al. Composition and three-dimensional architecture of the dengue virus replication and assembly sites. Cell Host Microbe. 2009;5(4):365\u201375.","journal-title":"Cell Host Microbe"},{"issue":"1","key":"2955_CR51","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1128\/jvi.71.1.291-298.1997","volume":"71","author":"IR Muylaert","year":"1997","unstructured":"Muylaert IR, Galler R, Rice CM. Genetic analysis of the yellow fever virus NS1 protein: identification of a temperature-sensitive mutation which blocks RNA accumulation. J Virol. 1997;71(1):291\u20138.","journal-title":"J Virol"},{"issue":"12","key":"2955_CR52","doi-asserted-by":"publisher","first-page":"9608","DOI":"10.1128\/jvi.71.12.9608-9617.1997","volume":"71","author":"BD Lindenbach","year":"1997","unstructured":"Lindenbach BD, Rice CM. Trans-complementation of yellow fever virus NS1 reveals a role in early RNA replication. J Virol. 1997;71(12):9608\u201317.","journal-title":"J Virol"},{"issue":"11","key":"2955_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005277","volume":"11","author":"P Scaturro","year":"2015","unstructured":"Scaturro P, Cortese M, Chatel-Chaix L, Fischl W, Bartenschlager R. Dengue virus non-structural protein 1 modulates infectious particle production via interaction with the structural proteins. PLoS Pathog. 2015;11(11):e1005277.","journal-title":"PLoS Pathog"},{"issue":"Pt 6","key":"2955_CR54","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1099\/0022-1317-72-6-1331","volume":"72","author":"P Despres","year":"1991","unstructured":"Despres P, Girard M, Bouloy M. Characterization of yellow fever virus proteins E and NS1 expressed in Vero and spodoptera frugiperda cells. J Gen Virol. 1991;72(Pt 6):1331\u201342.","journal-title":"J Gen Virol"},{"issue":"Pt 10","key":"2955_CR55","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1099\/vir.0.83620-0","volume":"89","author":"S Noisakran","year":"2008","unstructured":"Noisakran S, Dechtawewat T, Avirutnan P, Kinoshita T, Siripanyaphinyo U, Puttikhunt C, et al. Association of dengue virus NS1 protein with lipid rafts. J Gen Virol. 2008;89(Pt 10):2492\u2013500.","journal-title":"J Gen Virol"},{"issue":"11","key":"2955_CR56","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1096\/fj.99-0829com","volume":"14","author":"MG Jacobs","year":"2000","unstructured":"Jacobs MG, Robinson PJ, Bletchly C, Mackenzie JM, Young PR. Dengue virus nonstructural protein 1 is expressed in a glycosyl-phosphatidylinositol-linked form that is capable of signal transduction. FASEB J. 2000;14(11):1603\u201310.","journal-title":"FASEB J"},{"issue":"11","key":"2955_CR57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.0030183","volume":"3","author":"P Avirutnan","year":"2007","unstructured":"Avirutnan P, Zhang L, Punyadee N, Manuyakorn A, Puttikhunt C, Kasinrerk W, et al. Secreted NS1 of dengue virus attaches to the surface of cells via interactions with heparan sulfate and chondroitin sulfate E. PLoS Pathog. 2007;3(11):e183.","journal-title":"PLoS Pathog"},{"key":"2955_CR58","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jviromet.2015.06.006","volume":"222","author":"NK Stock","year":"2015","unstructured":"Stock NK, Escadafal C, Achazi K, Cisse M, Niedrig M. Development and characterization of polyclonal peptide antibodies for the detection of yellow fever virus proteins. J Virol Methods. 2015;222:110\u20136.","journal-title":"J Virol Methods"},{"issue":"1","key":"2955_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-16231-6","volume":"7","author":"T Ricciardi-Jorge","year":"2017","unstructured":"Ricciardi-Jorge T, Bordignon J, Koishi A, Zanluca C, Mosimann AL, Duarte Dos Santos CN. Development of a quantitative NS1-capture enzyme-linked immunosorbent assay for early detection of yellow fever virus infection. Sci Rep. 2017;7(1):16229.","journal-title":"Sci Rep"},{"issue":"2","key":"2955_CR60","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2023.2212812","volume":"12","author":"X Wang","year":"2023","unstructured":"Wang X, Usama A, Huanchun C, Cao S, Ye J. Biological determinants perpetuating the transmission dynamics of mosquito-borne flaviviruses. Emerg Microbes Infect. 2023;12(2):2212812.","journal-title":"Emerg Microbes Infect"},{"issue":"9","key":"2955_CR61","doi-asserted-by":"publisher","first-page":"16087","DOI":"10.1038\/nmicrobiol.2016.87","volume":"1","author":"J Liu","year":"2016","unstructured":"Liu J, Liu Y, Nie K, Du S, Qiu J, Pang X, et al. Flavivirus NS1 protein in infected host sera enhances viral acquisition by mosquitoes. Nat Microbiol. 2016;1(9):16087.","journal-title":"Nat Microbiol"},{"issue":"3","key":"2955_CR62","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3390\/insects9030095","volume":"9","author":"A Kumar","year":"2018","unstructured":"Kumar A, Srivastava P, Sirisena P, Dubey SK, Kumar R, Shrinet J, et al. Mosquito Innate Immunity. Insects. 2018;9(3):95.","journal-title":"Insects"},{"issue":"21","key":"2955_CR63","doi-asserted-by":"publisher","first-page":"3857","DOI":"10.1016\/j.cell.2022.09.023","volume":"185","author":"RL Philips","year":"2022","unstructured":"Philips RL, Wang Y, Cheon H, Kanno Y, Gadina M, Sartorelli V, et al. The JAK-STAT pathway at 30: much learned, much more to do. Cell. 2022;185(21):3857\u201376.","journal-title":"Cell"},{"issue":"8","key":"2955_CR64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007299","volume":"13","author":"L Danet","year":"2019","unstructured":"Danet L, Beauclair G, Berthet M, Moratorio G, Gracias S, Tangy F, et al. Midgut barriers prevent the replication and dissemination of the yellow fever vaccine in Aedes aegypti. PLoS Negl Trop Dis. 2019;13(8):e0007299.","journal-title":"PLoS Negl Trop Dis"},{"key":"2955_CR65","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4269\/ajtmh.1939.s1-19.19","volume":"19","author":"L Whitman","year":"1939","unstructured":"Whitman L. Failure of A\u00ebdes aegypti to transmit yellow fever cultured virus (17D)1. Am J Trop Med Hyg. 1939;19:19\u201326.","journal-title":"Am J Trop Med Hyg"},{"issue":"Pt 10","key":"2955_CR66","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1099\/vir.0.82023-0","volume":"87","author":"KL McElroy","year":"2006","unstructured":"McElroy KL, Tsetsarkin KA, Vanlandingham DL, Higgs S. Role of the yellow fever virus structural protein genes in viral dissemination from the Aedes aegypti mosquito midgut. J Gen Virol. 2006;87(Pt 10):2993\u20133001.","journal-title":"J Gen Virol"},{"issue":"1","key":"2955_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-32198-4","volume":"8","author":"F Amraoui","year":"2018","unstructured":"Amraoui F, Pain A, Piorkowski G, Vazeille M, Couto-Lima D, de Lamballerie X, et al. Experimental adaptation of the yellow fever virus to the mosquito Aedes albopictus and potential risk of urban epidemics in Brazil, South America. Sci Rep. 2018;8(1):14337.","journal-title":"Sci Rep"},{"issue":"3","key":"2955_CR68","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41569-022-00770-1","volume":"20","author":"E Trimm","year":"2023","unstructured":"Trimm E, Red-Horse K. Vascular endothelial cell development and diversity. Nat Rev Cardiol. 2023;20(3):197\u2013210.","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"2955_CR69","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00424-007-0212-8","volume":"454","author":"S Reitsma","year":"2007","unstructured":"Reitsma S, Slaaf DW, Vink H, van Zandvoort MA, oude Egbrink MG. The endothelial glycocalyx: composition, functions, and visualization. Pflugers Arch. 2007;454(3):345\u201359.","journal-title":"Pflugers Arch"},{"issue":"7","key":"2955_CR70","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1111\/anae.12661","volume":"69","author":"CS Alphonsus","year":"2014","unstructured":"Alphonsus CS, Rodseth RN. The endothelial glycocalyx: a review of the vascular barrier. Anaesthesia. 2014;69(7):777\u201384.","journal-title":"Anaesthesia"},{"issue":"7","key":"2955_CR71","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007938","volume":"15","author":"C Wang","year":"2019","unstructured":"Wang C, Puerta-Guardo H, Biering SB, Glasner DR, Tran EB, Patana M, et al. Endocytosis of flavivirus NS1 is required for NS1-mediated endothelial hyperpermeability and is abolished by a single N-glycosylation site mutation. PLoS Pathog. 2019;15(7):e1007938.","journal-title":"PLoS Pathog"},{"key":"2955_CR72","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.545813","volume":"7","author":"PK Lam","year":"2020","unstructured":"Lam PK, McBride A, Le DHT, Huynh TT, Vink H, Wills B, et al. Visual and biochemical evidence of glycocalyx disruption in human dengue infection, and association with plasma leakage severity. Front Med Lausanne. 2020;7:545813.","journal-title":"Front Med Lausanne"},{"issue":"304","key":"2955_CR73","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaa3863","volume":"7","author":"N Modhiran","year":"2015","unstructured":"Modhiran N, Watterson D, Muller DA, Panetta AK, Sester DP, Liu L, et al. Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity. Sci Transl Med. 2015;7(304):304ra142.","journal-title":"Sci Transl Med"},{"issue":"3","key":"2955_CR74","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0012071","volume":"18","author":"A McBride","year":"2024","unstructured":"McBride A, Duyen HTL, Vuong NL, Tho PV, Tai LTH, Phong NT, et al. Endothelial and inflammatory pathophysiology in dengue shock: new insights from a prospective cohort study in Vietnam. PLoS Negl Trop Dis. 2024;18(3):e0012071.","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"2955_CR75","first-page":"992","volume":"215","author":"S Suwarto","year":"2017","unstructured":"Suwarto S, Sasmono RT, Sinto R, Ibrahim E, Suryamin M. Association of endothelial glycocalyx and tight and adherens junctions with severity of plasma leakage in dengue infection. J Infect Dis. 2017;215(6):992\u20139.","journal-title":"J Infect Dis"},{"key":"2955_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.759570","volume":"12","author":"B Buijsers","year":"2021","unstructured":"Buijsers B, Garishah FM, Riswari SF, van Ast RM, Pramudo SG, Tunjungputri RN, et al. Increased plasma heparanase activity and endothelial glycocalyx degradation in dengue patients is associated with plasma leakage. Front Immunol. 2021;12:759570.","journal-title":"Front Immunol"},{"issue":"8","key":"2955_CR77","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1086\/343813","volume":"186","author":"DH Libraty","year":"2002","unstructured":"Libraty DH, Young PR, Pickering D, Endy TP, Kalayanarooj S, Green S, et al. High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. J Infect Dis. 2002;186(8):1165\u20138.","journal-title":"J Infect Dis"},{"issue":"6","key":"2955_CR78","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.celrep.2019.01.036","volume":"26","author":"H Puerta-Guardo","year":"2019","unstructured":"Puerta-Guardo H, Glasner DR, Espinosa DA, Biering SB, Patana M, Ratnasiri K, et al. Flavivirus NS1 triggers Tissue-Specific vascular endothelial dysfunction reflecting disease tropism. Cell Rep. 2019;26(6):1598\u2013613. e8.","journal-title":"Cell Rep"},{"key":"2955_CR79","doi-asserted-by":"publisher","first-page":"105409","DOI":"10.1016\/j.ebiom.2024.105409","volume":"109","author":"FTG de Sousa","year":"2024","unstructured":"de Sousa FTG, Warnes CM, Manuli ER, Ng A, D\u2019Elia Zanella L, Ho YL, et al. Yellow fever disease severity and endothelial dysfunction are associated with elevated serum levels of viral NS1 protein and syndecan-1. EBioMedicine. 2024;109:105409.","journal-title":"EBioMedicine"},{"issue":"1","key":"2955_CR80","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0009028","volume":"15","author":"R Raulino","year":"2021","unstructured":"Raulino R, Thaurignac G, Butel C, Villabona-Arenas CJ, Foe T, Loul S, et al. Multiplex detection of antibodies to Chikungunya, O\u2019nyong-nyong, Zika, Dengue, West Nile and Usutu viruses in diverse non-human primate species from Cameroon and the Democratic Republic of Congo. PLoS Negl Trop Dis. 2021;15(1):e0009028.","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"2955_CR81","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2023.2301666","volume":"13","author":"GH Chen","year":"2024","unstructured":"Chen GH, Dai YC, Hsieh SC, Tsai JJ, Sy AK, Jiz M, et al. Detection of anti-premembrane antibody as a specific marker of four flavivirus serocomplexes and its application to serosurveillance in endemic regions. Emerg Microbes Infect. 2024;13(1):2301666.","journal-title":"Emerg Microbes Infect"},{"issue":"5","key":"2955_CR82","doi-asserted-by":"publisher","first-page":"e0151623","DOI":"10.1128\/jvi.01516-23","volume":"98","author":"N Mantel","year":"2024","unstructured":"Mantel N, Piras-Douce F, Chautard E, Marcos-Lopez E, Bodinham CL, Cosma A, et al. Cynomolgus macaques as a translational model of human immune responses to yellow fever 17D vaccination. J Virol. 2024;98(5):e0151623.","journal-title":"J Virol"},{"issue":"2","key":"2955_CR83","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/s41564-024-01903-7","volume":"10","author":"S Kalimuddin","year":"2025","unstructured":"Kalimuddin S, Tham CYL, Chan YFZ, Hang SK, Kunasegaran K, Chia A, et al. Vaccine-induced T cell responses control orthoflavivirus challenge infection without neutralizing antibodies in humans. Nat Microbiol. 2025;10(2):374\u201387.","journal-title":"Nat Microbiol"},{"issue":"7","key":"2955_CR84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004821","volume":"10","author":"S Gailhardou","year":"2016","unstructured":"Gailhardou S, Skipetrova A, Dayan GH, Jezorwski J, Saville M, Van der Vliet D, et al. Safety overview of a recombinant live-attenuated tetravalent dengue vaccine: pooled analysis of data from 18 clinical trials. PLoS Negl Trop Dis. 2016;10(7):e0004821.","journal-title":"PLoS Negl Trop Dis"},{"issue":"13","key":"2955_CR85","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1056\/NEJMoa1506223","volume":"373","author":"SR Hadinegoro","year":"2015","unstructured":"Hadinegoro SR, Arredondo-Garcia JL, Capeding MR, Deseda C, Chotpitayasunondh T, Dietze R, et al. Efficacy and long-term safety of a dengue vaccine in regions of endemic disease. N Engl J Med. 2015;373(13):1195\u2013206.","journal-title":"N Engl J Med"},{"key":"2955_CR86","doi-asserted-by":"crossref","unstructured":"Halstead SB. Which dengue vaccine approach is the most promising, and should we be concerned about enhanced disease after vaccination? There is only one true winner. Cold Spring Harb Perspect Biol. 2018;10(6).","DOI":"10.1101\/cshperspect.a030700"},{"issue":"6","key":"2955_CR87","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1093\/infdis\/jiz081","volume":"221","author":"M Sharma","year":"2020","unstructured":"Sharma M, Glasner DR, Watkins H, Puerta-Guardo H, Kassa Y, Egan MA, et al. Magnitude and functionality of the NS1-specific antibody response elicited by a live-attenuated tetravalent dengue vaccine candidate. J Infect Dis. 2020;221(6):867\u201377.","journal-title":"J Infect Dis"},{"issue":"4","key":"2955_CR88","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1586\/14760584.2016.1115727","volume":"15","author":"SS Whitehead","year":"2016","unstructured":"Whitehead SS. Development of TV003\/TV005, a single dose, highly immunogenic live attenuated dengue vaccine; what makes this vaccine different from the Sanofi-Pasteur CYD\u2122 vaccine? Expert Rev Vaccines. 2016;15(4):509\u201317.","journal-title":"Expert Rev Vaccines"},{"issue":"9857","key":"2955_CR89","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1016\/S0140-6736(12)61151-9","volume":"380","author":"AM Kilpatrick","year":"2012","unstructured":"Kilpatrick AM, Randolph SE. Drivers, dynamics, and control of emerging vector-borne zoonotic diseases. Lancet. 2012;380(9857):1946\u201355.","journal-title":"Lancet"},{"key":"2955_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2023.106983","volume":"245","author":"R Wilk-da-Silva","year":"2023","unstructured":"Wilk-da-Silva R, Prist PR, Medeiros-Sousa AR, Laporta GZ, Mucci LF, Marrelli MT. The role of forest fragmentation in yellow fever virus dispersal. Acta Trop. 2023;245:106983.","journal-title":"Acta Trop"},{"issue":"4","key":"2955_CR91","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.4049\/jimmunol.135.4.2805","volume":"135","author":"JJ Schlesinger","year":"1985","unstructured":"Schlesinger JJ, Brandriss MW, Walsh EE. Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48. J Immunol. 1985;135(4):2805\u20139.","journal-title":"J Immunol"},{"issue":"Pt 8","key":"2955_CR92","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1099\/0022-1317-71-8-1697","volume":"71","author":"JR Putnak","year":"1990","unstructured":"Putnak JR, Schlesinger JJ. Protection of mice against yellow fever virus encephalitis by immunization with a vaccinia virus recombinant encoding the yellow fever virus non-structural proteins, NS1, NS2a and NS2b. J Gen Virol. 1990;71(Pt 8):1697\u2013702.","journal-title":"J Gen Virol"},{"key":"2955_CR93","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.coviro.2016.03.010","volume":"18","author":"JG Julander","year":"2016","unstructured":"Julander JG. Animal models of yellow fever and their application in clinical research. Curr Opin Virol. 2016;18:64\u20139.","journal-title":"Curr Opin Virol"},{"issue":"3","key":"2955_CR94","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1089\/vbz.2019.2495","volume":"20","author":"MA McArthur","year":"2020","unstructured":"McArthur MA, Zhang SL, Li L, Tesh RB, Barrett ADT. Molecular characterization of hamster-adapted yellow fever virus. Vector Borne Zoonotic Dis. 2020;20(3):222\u20137.","journal-title":"Vector Borne Zoonotic Dis"},{"issue":"11","key":"2955_CR95","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003295","volume":"8","author":"F Engelmann","year":"2014","unstructured":"Engelmann F, Josset L, Girke T, Park B, Barron A, Dewane J, et al. Pathophysiologic and transcriptomic analyses of viscerotropic yellow fever in a rhesus macaque model. PLoS Negl Trop Dis. 2014;8(11):e3295.","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"2955_CR96","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1128\/jvi.60.3.1153-1155.1986","volume":"60","author":"JJ Schlesinger","year":"1986","unstructured":"Schlesinger JJ, Brandriss MW, Cropp CB, Monath TP. Protection against yellow fever in monkeys by immunization with yellow fever virus nonstructural protein NS1. J Virol. 1986;60(3):1153\u20135.","journal-title":"J Virol"},{"issue":"0077340","key":"2955_CR97","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1099\/0022-1317-69-6-1241","volume":"69","author":"PA Cane","year":"1988","unstructured":"Cane PA, Gould EA. Reduction of yellow fever virus mouse neurovirulence by immunization with a bacterially synthesized non-structural protein (NS1) fragment. J Gen Virol. 1988;69(0077340):1241\u20136. (Pt 6)(i9b.","journal-title":"J Gen Virol"},{"issue":"6525","key":"2955_CR98","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1126\/science.abc0476","volume":"371","author":"SB Biering","year":"2021","unstructured":"Biering SB, Akey DL, Wong MP, Brown WC, Lo NTN, Puerta-Guardo H, et al. Structural basis for antibody inhibition of flavivirus NS1-triggered endothelial dysfunction. Science. 2021;371(6525):194\u2013200.","journal-title":"Science"},{"issue":"1","key":"2955_CR99","doi-asserted-by":"publisher","first-page":"6975","DOI":"10.1038\/s41598-017-07308-3","volume":"7","author":"YC Lai","year":"2017","unstructured":"Lai YC, Chuang YC, Liu CC, Ho TS, Lin YS, Anderson R, et al. Antibodies against modified NS1 wing domain peptide protect against dengue virus infection. Sci Rep. 2017;7(1):6975.","journal-title":"Sci Rep"},{"key":"2955_CR100","doi-asserted-by":"crossref","unstructured":"Mishra N, Boudewijns R, Schmid MA, Marques RE, Sharma S, Neyts J, et al. A chimeric japanese encephalitis vaccine protects against lethal yellow fever virus infection without inducing neutralizing antibodies. mBio. 2020;11(2).","DOI":"10.1128\/mBio.02494-19"},{"issue":"1","key":"2955_CR101","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1080\/22221751.2020.1730709","volume":"9","author":"DB Kum","year":"2020","unstructured":"Kum DB, Boudewijns R, Ma J, Mishra N, Schols D, Neyts J, et al. A chimeric yellow fever-Zika virus vaccine candidate fully protects against yellow fever virus infection in mice. Emerg Microbes Infect. 2020;9(1):520\u201333.","journal-title":"Emerg Microbes Infect"},{"issue":"1","key":"2955_CR102","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nri.2017.106","volume":"18","author":"LL Lu","year":"2018","unstructured":"Lu LL, Suscovich TJ, Fortune SM, Alter G. Beyond binding: antibody effector functions in infectious diseases. Nat Rev Immunol. 2018;18(1):46\u201361.","journal-title":"Nat Rev Immunol"},{"issue":"651","key":"2955_CR103","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abm3151","volume":"14","author":"Jr. AG Dias","year":"2022","unstructured":"Dias AG Jr., Atyeo C, Loos C, Montoya M, Roy V, Bos S, et al. Antibody Fc characteristics and effector functions correlate with protection from symptomatic dengue virus type 3 infection. Sci Transl Med. 2022;14(651):eabm3151.","journal-title":"Sci Transl Med"},{"issue":"1","key":"2955_CR104","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1006\/viro.1993.1015","volume":"192","author":"JJ Schlesinger","year":"1993","unstructured":"Schlesinger JJ, Foltzer M, Chapman S. The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against YF encephalitis in mice. Virology. 1993;192(1):132\u201341.","journal-title":"Virology"},{"issue":"1","key":"2955_CR105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1084\/jem.161.1.1","volume":"161","author":"TJ Kipps","year":"1985","unstructured":"Kipps TJ, Parham P, Punt J, Herzenberg LA. Importance of immunoglobulin isotype in human antibody-dependent, cell-mediated cytotoxicity directed by murine monoclonal antibodies. J Exp Med. 1985;161(1):1\u201317.","journal-title":"J Exp Med"},{"issue":"Pt 3","key":"2955_CR106","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1099\/0022-1317-68-3-853","volume":"68","author":"JJ Schlesinger","year":"1987","unstructured":"Schlesinger JJ, Brandriss MW, Walsh EE. Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1. J Gen Virol. 1987;68(Pt 3):853\u20137.","journal-title":"J Gen Virol"},{"issue":"4","key":"2955_CR107","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.4049\/jimmunol.1801323","volume":"202","author":"DA Espinosa","year":"2019","unstructured":"Espinosa DA, Beatty PR, Reiner GL, Sivick KE, Hix Glickman L, Dubensky TW Jr., et al. Cyclic dinucleotide-adjuvanted dengue virus nonstructural protein 1 induces protective antibody and T cell responses. J Immunol. 2019;202(4):1153\u201362.","journal-title":"J Immunol"},{"issue":"304","key":"2955_CR108","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaa3787","volume":"7","author":"PR Beatty","year":"2015","unstructured":"Beatty PR, Puerta-Guardo H, Killingbeck SS, Glasner DR, Hopkins K, Harris E. Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination. Sci Transl Med. 2015;7(304):304ra141.","journal-title":"Sci Transl Med"},{"key":"2955_CR109","doi-asserted-by":"crossref","unstructured":"Bailey MJ, Broecker F, Duehr J, Arumemi F, Krammer F, Palese P, et al. Antibodies elicited by an NS1-based vaccine protect mice against zika virus. mBio. 2019;10(2).","DOI":"10.1128\/mBio.02861-18"},{"issue":"1","key":"2955_CR110","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-023-00629-7","volume":"8","author":"LG Medina-Magues","year":"2023","unstructured":"Medina-Magues LG, Muhe J, Jasny E, Medina-Magues ES, Roth N, Lopera-Madrid J, et al. Immunogenicity and protective activity of mRNA vaccine candidates against yellow fever virus in animal models. NPJ Vaccines. 2023;8(1):31.","journal-title":"NPJ Vaccines"},{"issue":"0077340","key":"2955_CR111","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1099\/0022-1317-66-7-1369","volume":"66","author":"EA Gould","year":"1985","unstructured":"Gould EA, Buckley A, Cammack N, Barrett AD, Clegg JC, Ishak R, et al. Examination of the immunological relationships between flaviviruses using yellow fever virus monoclonal antibodies. J Gen Virol. 1985;66(0077340):1369\u201382. (Pt 7)(i9b.","journal-title":"J Gen Virol"},{"issue":"Pt 3","key":"2955_CR112","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1099\/0022-1317-67-3-591","volume":"67","author":"EA Gould","year":"1986","unstructured":"Gould EA, Buckley A, Barrett AD, Cammack N. Neutralizing (54K) and non-neutralizing (54K and 48K) monoclonal antibodies against structural and non-structural yellow fever virus proteins confer immunity in mice. J Gen Virol. 1986;67(Pt 3):591\u20135.","journal-title":"J Gen Virol"},{"issue":"3\u20134","key":"2955_CR113","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/BF01310727","volume":"94","author":"V Deubel","year":"1987","unstructured":"Deubel V, Schlesinger JJ, Digoutte JP, Girard M. Comparative immunochemical and biological analysis of African and South American yellow fever viruses. Arch Virol. 1987;94(3\u20134):331\u20138.","journal-title":"Arch Virol"},{"issue":"1","key":"2955_CR114","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/0042-6822(83)90059-4","volume":"125","author":"JJ Schlesinger","year":"1983","unstructured":"Schlesinger JJ, Brandris MW, Monath TP. Monoclonal antibodies distinguish between wild and vaccine strains of yellow fever virus by neutralization, hemagglutination inhibition, and immune precipitation of the virus envelope protein. Virology. 1983;125(1):8\u201317.","journal-title":"Virology"},{"issue":"4","key":"2955_CR115","doi-asserted-by":"publisher","first-page":"695","DOI":"10.4269\/ajtmh.1984.33.695","volume":"33","author":"TP Monath","year":"1984","unstructured":"Monath TP, Schlesinger JJ, Brandriss MW, Cropp CB, Prange WC. Yellow fever monoclonal antibodies: type-specific and cross-reactive determinants identified by immunofluorescence. Am J Trop Med Hyg. 1984;33(4):695\u20138.","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"2955_CR116","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1128\/JCM.02735-14","volume":"53","author":"DY Chao","year":"2015","unstructured":"Chao DY, Galula JU, Shen WF, Davis BS, Chang GJ. Nonstructural protein 1-specific immunoglobulin m and g antibody capture enzyme-linked immunosorbent assays in diagnosis of flaviviral infections in humans. J Clin Microbiol. 2015;53(2):557\u201366.","journal-title":"J Clin Microbiol"},{"issue":"7\u20138","key":"2955_CR117","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/S0264-410X(01)00457-1","volume":"20","author":"TP Monath","year":"2002","unstructured":"Monath TP, McCarthy K, Bedford P, Johnson CT, Nichols R, Yoksan S, et al. Clinical proof of principle for chimerivax: recombinant live, attenuated vaccines against flavivirus infections. Vaccine. 2002;20(7\u20138):1004\u201318.","journal-title":"Vaccine"},{"key":"2955_CR118","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.3389\/fimmu.2020.01836","volume":"11","author":"A Stryhn","year":"2020","unstructured":"Stryhn A, Kongsgaard M, Rasmussen M, Harndahl MN, Osterbye T, Bassi MR, et al. A Systematic, unbiased mapping of CD8(+) and CD4(+) T cell epitopes in yellow fever vaccinees. Front Immunol. 2020;11:1836.","journal-title":"Front Immunol"},{"issue":"23","key":"2955_CR119","doi-asserted-by":"publisher","first-page":"12794","DOI":"10.1128\/JVI.01160-13","volume":"87","author":"EA James","year":"2013","unstructured":"James EA, LaFond RE, Gates TJ, Mai DT, Malhotra U, Kwok WW. Yellow fever vaccination elicits broad functional CD4\u2009+\u2009t cell responses that recognize structural and nonstructural proteins. J Virol. 2013;87(23):12794\u2013804.","journal-title":"J Virol"},{"issue":"10","key":"2955_CR120","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1073\/pnas.1500475112","volume":"112","author":"RS Akondy","year":"2015","unstructured":"Akondy RS, Johnson PL, Nakaya HI, Edupuganti S, Mulligan MJ, Lawson B, et al. Initial viral load determines the magnitude of the human CD8 T cell response to yellow fever vaccination. Proc Natl Acad Sci U S A. 2015;112(10):3050\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2955_CR121","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1006\/viro.2001.1255","volume":"293","author":"MD Co","year":"2002","unstructured":"Co MD, Terajima M, Cruz J, Ennis FA, Rothman AL. Human cytotoxic T lymphocyte responses to live attenuated 17D yellow fever vaccine: identification of HLA-B35-restricted CTL epitopes on nonstructural proteins NS1, NS2b, NS3, and the structural protein E. Virology. 2002;293(1):151\u201363.","journal-title":"Virology"},{"issue":"5","key":"2955_CR122","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.4049\/jimmunol.1202234","volume":"190","author":"K Blom","year":"2013","unstructured":"Blom K, Braun M, Ivarsson MA, Gonzalez VD, Falconer K, Moll M, et al. Temporal dynamics of the primary human T cell response to yellow fever virus 17D as it matures from an effector- to a memory-type response. J Immunol. 2013;190(5):2150\u20138.","journal-title":"J Immunol"},{"issue":"282","key":"2955_CR123","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaa3700","volume":"7","author":"SA Fuertes Marraco","year":"2015","unstructured":"Fuertes Marraco SA, Soneson C, Cagnon L, Gannon PO, Allard M, Abed Maillard S, et al. Long-lasting stem cell-like memory CD8\u2009+\u2009T cells with a na\u00efve-like profile upon yellow fever vaccination. Sci Transl Med. 2015;7(282):282ra48.","journal-title":"Sci Transl Med"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02955-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-025-02955-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02955-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:03:36Z","timestamp":1761087816000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-025-02955-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":123,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2955"],"URL":"https:\/\/doi.org\/10.1186\/s12985-025-02955-9","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"3 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"338"}}